KBL Merger Co. IV (KBLM) Shareholders Approve CannBioRx Deal

proxy vote

KBL Merger Co. IV (KBLM) Shareholders Approve CannBioRx Deal

KBL Merger Co. IV (NASDAQ:KBLM) announced in an 8-K filing this afternoon that its shareholders approved its merger with CannBioRx Life Sciences Corp at a special meeting November 5, but also redeemed shares worth most of its trust value. A total of 816,461 shares were redeemed, removing about $9 million from its trust and leaving
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Leave a Reply